178
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Initial heart rate and cardiovascular outcomes in patients presenting with acute coronary syndrome

, , , , , , , , , , , , & show all
Pages 49-56 | Received 04 Sep 2013, Accepted 14 Jan 2014, Published online: 04 Apr 2014

References

  • Fácila L, Morillas P, Quiles J, Soria F, Cordero A, Mazón P, et al. Investigators OB. Prognostic significance of heart rate in hospitalized patients presenting with myocardial infarction. World J Cardiol. 2012;4:15–9.
  • Kannel W, Kannel C, Paffenbarger R, Cupples L. Heart rate and cardiovascular mortality: The Framingham Study. Am Heart J. 1987;113:1489–94.
  • Palatini P, Julius S. Elevated heart rate: A major risk factor for cardiovascular disease. Clin Exp Hypertens. 2004;26:637–44.
  • Diaz A, Bourassa M, Guertin M, Tardif J. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J. 2005;26:967–74.
  • Kolloch R, Legler U, Champion A, Cooper-Dehoff RM, Handberg E, Zhou Q, et al. Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: Findings from the international verapamil-SR/trandolapril study (INVEST). Eur Heart J. 2008;29:1327–34.
  • Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R; BEAUTIFUL investigators. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): A subgroup analysis of a randomised controlled trial. Lancet 2008;372:817–21.
  • Dyer A, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM, et al. Heart rate as a prognostic factor for coronary heart disease and mortality: Findings in three Chicago epidemiologic studies. Am J Epidemiol.1980;112:736–49.
  • Madsen E, Gilpin E, Henning H. Prediction of late mortality after myocardial infarction from variables measured at different times during hospitalization. Am J Cardiol. 1984;53:47–54.
  • Hjalmarson A, Gilpin EA, Kjekshus J, Schieman G, Nicod P, Henning H, et al. Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol.1990;65:547–53.
  • Zuanetti G, Mantini L, Hernández-Bernal F, Barlera S, di Gregorio D, Latini R, et al. Relevance of heart rate as a prognostic factor in patients with acute myocardial infarction: Insight from the GISSI-2 study. Eur Heart J. 1998;19(Suppl. F):19–26.
  • Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J, et al.; for the GUSTO-I investigators. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: Results from an international trial of 41,021 patients. Circulation 1995;91:1659–68.
  • Boersma E, Pieper K, Steyerberg E. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: Results from an international trial of 9,461 patients. Circulation 2000;101:2557–67.
  • Kovar D, Cannon CP, Bentley JH, Charlesworth A, Rogers WJ. Does initial and delayed heart rate predict mortality in patients with acute coronary syndromes?. Clin Cardiol. 2004;27:80–6.
  • López-Sendón J, Gurfinkel EP, Lopez de Sa E, Agnelli G, Gore JM, Steg PG, et al. Factors related to heart rupture in acute coronary syndromes in the global registry of acute coronary events. Eur Heart J. 2010;31:1449–56.
  • Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163: 2345–53.
  • El-Menyar A, Zubaid M, Shehab A, Bulbanat B, Albustani N, Alenezi F, et al. Prevalence and impact of cardiovascular risk factors among patients presenting with acute coronary syndrome in the Middle East. Clin Cardiol. 2011;34:51–8.
  • El-Menyar A, AlHabib KF, Al-Motarreb A, Hersi A, Al Faleh H, Asaad N, et al. Prior antiplatelet use and cardiovascular outcomes in patients presenting with acute coronary syndrome. Am J Cardiovasc Drugs. 2012;12:127–35.
  • Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology task force on clinical data standards (acute coronary syndromes writing committee). J Am Coll Cardiol. 2001;38:2114–30.
  • Giannoglou GD, Chatzizisis YS, Zamboulis C, Parcharidis GE, Mikhailidis DP, Louridas GE. Elevated heart rate and atherosclerosis: An overview of the pathogenetic mechanisms. Int J Cardiol. 2008;26:302–12.
  • Andrikopoulos G, Pastromas S, Kartalis A, Toli K, Mantas I, Tzeis S, et al. Inadequate heart rate control is associated with worse quality of life in patients with coronary artery disease and chronic obstructive pulmonary disease. The RYTHMOS study. Hellenic J Cardiol. 2012;53:118–26.
  • Copie X, Hnatkova K, Staunton A, Fei L, Camm AJ, Malik M. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study. J Am Coll Cardiol. 1996;27:270–6.
  • Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335–71.
  • Bangalore S, Messerli FH, Ou FS, Tamis-Holland J, Palazzo A, Roe MT, et al. The association of admission heart rate and in-hospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes: Results from 135 164 patients in the CRUSADE quality improvement initiative. Eur Heart J. 2010;31:552–60.
  • Braunwald E, Jones RH, Mark DB, Brown J, Brown L, Cheitlin MD, et al. Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. Circulation 1994; 90:613–22.
  • Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 2011;123:e426–e579.
  • Parodi G, Bellandi B, Valenti R, Memisha G, Giuliani G, Velluzzi S, et al. Heart rate as an independent prognostic risk factor in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Atherosclerosis 2010;211:255–59.
  • Aguiar A, Ricardo Mourilhe-Rocha R, Esporcatte R. Long-term analysis in acute coronary syndrome: Are there any differences in morbidity and mortality?Arq Bras Cardiol. 2010;95:705–12.
  • Umbrasiene E, Ventsloviene Ĭ, Babarskiene RM. Resting heart rate and one year mortality association in patients with coronary heart disease. Kardiologiia 2011;51:15–20.
  • Disegni E, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Zion M, Boyko V, et al. The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT study group. Secondary prevention reinfarction Israeli nifedipine trial. J Clin Epidemiol. 1995;48:1197–205.
  • Julius S, Pascual A, London R. Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation 1971;44:413–8.
  • Heidland U, Strauer B. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 2001;104:1477–82.
  • Palatini P, Casiglia E, Julius S, Pessina A. High heart rate: A risk factor for cardiovascular death in elderly men. Arch Intern Med. 1999;159:585–92.
  • Tardif JC, Ford I, Tendera M, Bourassa MG, Fox K; INITIATIVE Investigators. Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J. 2005;26:2529–36.
  • Dominguez-Rodriguez A, Blanco-Palacios G, Abreu-Gonzalez P. Increased heart rate and atherosclerosis: Potential implications of ivabradine therapy. World J Cardiol. 2011;3:101–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.